JNJ · Healthcare
JOHNSON & JOHNSON
Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window
News · 2026-08-07
- Talc Litigation SettlementImportance 71 · Surprise 60Johnson & Johnson agreed to a $5.5 billion settlement to resolve tens of thousands of talc baby-powder lawsuits in the United States. The settlement addresses decades of claims alleging health risks from talc products…
News · 2026-08-06
- Accrued Legal and RegulatoryImportance 71 · Surprise 60Johnson & Johnson agreed to a $5.5 billion settlement covering tens of thousands of talc baby-powder lawsuits. The settlement is intended to resolve decades of litigation concerning alleged health risks from talc…
- Manufacturing capacity expansionImportance 46 · Surprise 42Johnson & Johnson committed more than $1 billion to increase production of contact lenses in the United States. The investment is intended to expand the supply of American-made contact lenses. Medicare coverage remains…
8-K · 2026-08-04
- Leadership TransitionImportance 31 · Surprise 42Jennifer Taubert will retire as Executive Vice President and Worldwide Chairman of Johnson & Johnson’s Innovative Medicine business after more than 21 years with the company. The business grew to more than $60 billion…
News · 2026-08-04
- Capital Return ProgramImportance 44 · Surprise 24Johnson & Johnson returned $85 billion to shareholders during the past five years through dividends and share buybacks. The amount represents a material use of capital relative to the company's $25.31 billion revenue…
- Leadership TransitionImportance 31 · Surprise 42Jennifer Taubert will retire as Johnson & Johnson’s Executive Vice President and Worldwide Chairman of Innovative Medicine on September 1, 2026. Tom Cavanaugh, currently Company Group Chairman for North America,…